Replies to post #158641 on Biotech Values

[dav1234]

Acadia Pharmaceuticals (ACAD) continues to soar, now up over 27% after saying its drug candidate Pimavanserin worked very well reducing hallucinations and delusions related to Parkinson's Disease during Phase III testing

[dav1234]

congrats on ACAD..wow